Routine gynecologic care remains relevant well past age 70, even though several major screening guidelines use age-based cutoffs that can make it seem otherwise. The confusion is understandable: cervical cancer screening typically stops at 65, mammography guidelines often cap at 74, and the screening pelvic exam has been questioned for asymptomatic women of any age. But screening is only one reason people see a gynecologist. Vulvar and vaginal conditions, pelvic floor disorders, unexplained bleeding, sexual health concerns, and ongoing management of hormone therapy all become more common or more consequential with age, and many of these issues go unaddressed when older women assume they have aged out of gynecologic care.
What Happens to Cancer Screening After 65
Most guidelines recommend stopping cervical cancer screening at 65, provided you have had consistently normal results beforehand. That recommendation, however, has come under scrutiny. About one in five new cervical cancer diagnoses occurs in women older than 65, raising questions about whether age-based cutoffs leave a meaningful gap in detection.1PubMed Central. It’s time to re-evaluate cervical Cancer screening after age 65 Women who were never adequately screened, who have a history of abnormal results, or who have a weakened immune system may still benefit from continued cervical screening past the typical stopping age. If you fall into any of those categories, the decision to stop should be a conversation, not an automatic switch-off.
Breast cancer screening follows a similar pattern. Mammography has demonstrated clear benefits in reducing breast cancer deaths among women between 50 and 74, but most major organizations do not extend their recommendations past 74 because randomized trial data in that age group simply does not exist.2PubMed Central. Breast Cancer Screening in Older Women: The Importance of Shared Decision Making That is not the same as saying mammography is useless after 74. It means the evidence is incomplete, and the decision should factor in your overall health and how long you are likely to benefit from early detection. A healthy 76-year-old with a life expectancy of another decade is in a very different position than someone of the same age managing several serious chronic conditions.
Ovarian cancer screening is a different story entirely. No reliable screening method exists for ovarian cancer at any age. The U.S. Preventive Services Task Force recommends against screening for it, noting that even pelvic exams with bimanual palpation of the ovaries lack evidence of usefulness for this purpose.3JAMA. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement This means a gynecologic visit after 70 is not about trying to catch ovarian cancer early through a routine exam. It serves other purposes.
Vulvar and Vaginal Conditions That Increase With Age
The conditions most likely to bring an older woman to a gynecologist are not cancers but chronic vulvar and vaginal issues that become significantly more common after menopause. Genitourinary syndrome of menopause, often abbreviated GSM, is the umbrella term for the dryness, irritation, burning, painful urination, and recurrent urinary tract infections that result from declining estrogen levels. Estimates vary, but somewhere between half and 70 percent of postmenopausal women experience symptomatic GSM.4PubMed Central. Modern management of genitourinary syndrome of menopause Unlike hot flashes, which tend to ease over time, GSM tends to worsen the further you get from menopause. A woman in her seventies is often more affected than she was in her fifties.
The treatment options are well established. Topical estrogen creams or inserts applied directly to vaginal tissue remain the most common approach, and newer options include laser-based therapies, hyaluronic acid preparations, and selective estrogen receptor modulators.5Gynecology. Genitourinary syndrome of menopause: Important aspects of the pathogenesis, diagnosis, and treatment: A review Many women never seek treatment because they assume vaginal dryness and discomfort are inevitable parts of aging. They are common, but they are treatable, and a gynecologist is typically the specialist best positioned to manage them.
Beyond GSM, chronic vulvar skin conditions become more prevalent with age. A study comparing women over and under 50 found that those in the older group were significantly more likely to be diagnosed with lichen sclerosus, lichen planus, desquamative inflammatory vaginitis, and atrophic vaginitis.6PubMed. Chronic vulvovaginitis in women older than 50 years: analysis of a prospective database Lichen sclerosus deserves particular attention. It causes white, thinning patches of vulvar skin that can become intensely itchy and painful. Left untreated, it leads to progressive scarring and carries an elevated risk of vulvar cancer.7PubMed Central. Lichen Sclerosus-Presentation, Diagnosis and Management In one study, 87 percent of lichen sclerosus cases occurred in women over 50, and the rate of progression to vulvar neoplasia was higher in postmenopausal women than in younger patients.8PubMed Central. Clinical presentation differences of lichen sclerosus in pre- and post-menopausal women
These conditions require ongoing monitoring, typically by a gynecologist or a dermatologist experienced in vulvar disease. The monitoring visits are not about screening in the traditional sense. They are about managing a known condition and watching for changes that could signal something more serious. A woman with lichen sclerosus who stops seeing a gynecologist at 70 risks undetected progression.
Postmenopausal Bleeding Is Always Worth Investigating
Any vaginal bleeding that occurs after menopause demands evaluation, regardless of age. A large pooled analysis of over 40,000 women found that the overall risk of endometrial cancer among women presenting with postmenopausal bleeding was about 9 percent.9PubMed Central. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women That means roughly one in eleven women with this symptom had cancer. The risk climbs with age: women 55 and older with postmenopausal bleeding had substantially higher odds of endometrial cancer compared to younger postmenopausal women, and recurrent episodes and co-existing conditions like diabetes or hypertension raised the risk further.10PubMed Central. Risk Factors for Endometrial Carcinoma in Women with Postmenopausal Bleeding
This is one of the clearest reasons a woman over 70 may need a gynecologist promptly. Postmenopausal bleeding is not always cancer; it can result from atrophy, polyps, or hormonal medication. But the only way to rule out something dangerous is through proper evaluation, typically with ultrasound and sometimes tissue sampling. Dismissing bleeding as normal because you are past menopause is the mistake most likely to delay a cancer diagnosis.
Pelvic Floor Problems and Urinary Incontinence
Urinary incontinence becomes increasingly common in later life and has an outsized effect on daily functioning, social engagement, and mental health. It often goes unreported because women either consider it an expected consequence of aging or feel too embarrassed to bring it up. A gynecologist or urogynecologist is the specialist most familiar with the full range of options.
The encouraging news is that first-line treatments are noninvasive. Behavioral strategies and pelvic floor muscle training are recommended as the initial approach, and they work for a substantial proportion of women. Research shows that physiotherapy yields positive results in up to 80 percent of patients with mild stress urinary incontinence and in about half of those with moderate severity.11PubMed Central. Urinary incontinence in postmenopausal women – causes, symptoms, treatment These programs can be delivered in group settings as well as individually, which matters for accessibility. A randomized trial found that group-based pelvic floor muscle training reduced incontinence episodes by about 74 percent, comparable to individual sessions, suggesting it is a cost-effective and scalable option.12PubMed Central. Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women: A Randomized Clinical Trial
Surgical options exist for women who do not respond to conservative treatment, but the point is that you need to be evaluated first. A woman quietly managing leakage with pads and lifestyle restrictions for years may be a good candidate for a straightforward treatment plan she never knew existed. Pelvic organ prolapse, another common issue in this age group, follows a similar pattern: it is treatable, but only if someone examines you and discusses what options make sense for your situation.
Sexual Health Does Not Have an Expiration Date
A persistent cultural assumption holds that older women are not sexually active and therefore do not need sexual health care. Research tells a different story. A narrative review of studies on sexuality in aging women found that sexual expression is an enduring and adaptable aspect of identity rather than something that disappears with age. Women described navigating physical changes alongside powerful social forces including ageism, stigma, and what the researchers called “healthcare invisibility.”13PubMed Central. The qualitative experience of sexuality in ageing women: a narrative review Many women reframed sexual expression around intimacy and connection rather than focusing solely on intercourse, and a number highlighted evolving concerns such as the risk of sexually transmitted infections in midlife and later life.
STI risk in older adults is a real and underappreciated issue. Women who re-enter the dating pool after widowhood or divorce may not have received the safer-sex education that younger generations grew up with, and clinicians often fail to ask about sexual activity in older patients. GSM-related vaginal dryness and thinning also make vaginal tissue more susceptible to tearing and infection. A gynecologist who asks about sexual activity and screens for STIs when appropriate is providing care that a general practitioner may overlook.
Hormone Therapy After 65
For women already using systemic hormone therapy for menopausal symptoms, the question of whether to continue past 65 or 70 is one for a gynecologist to help navigate. The Menopause Society recognizes that there is no universal age limit for stopping hormone therapy. For healthy women with persistent bothersome symptoms, continuing past 65 may be reasonable with careful risk assessment. However, starting systemic hormone therapy for the first time at 65 or older carries measurably increased risks, including higher hazards of cancer, stroke, and heart disease, and the risks compound with longer duration of use.14Menopause. Initiation of Hormone Therapy After Age 65 Remains Risky but Still Works for Some Women
The distinction between systemic hormone therapy (pills, patches) and local vaginal estrogen matters here. Topical vaginal estrogen for GSM symptoms carries a much lower systemic absorption profile and is generally considered safer for long-term use in older women. This is the kind of nuance that a gynecologist manages: deciding whether you need systemic or local therapy, adjusting doses as you age, weighing your personal risk factors, and knowing when to switch to a non-hormonal alternative. Walking away from gynecologic care altogether means losing access to that ongoing calibration.
Why Age-Based Cutoffs Can Mislead
Screening guidelines use age cutoffs partly because the balance between benefit and harm shifts as people get older. A cancer found through screening only helps if the person lives long enough for treatment to make a difference, and screening carries its own costs: false positives, invasive follow-up procedures, and the anxiety that comes with them. That logic is sound in the aggregate. Where it breaks down is when a blanket age number replaces individual assessment.
Life expectancy is a more informative metric than calendar age when weighing screening decisions. A framework proposed in the geriatric oncology literature suggests that individualized decisions should factor in three things: the person’s overall health and estimated remaining years, their personal preferences and values, and how those factors interact with the specific harms and benefits of a given test.15PubMed Central. Cancer Screening in Older Adults: Individualized Decision-Making and Communication Strategies In practice, both clinicians and patients find the concept of life expectancy uncomfortable to discuss, which may explain why it is underused in real-world conversations about screening.16PubMed Central. Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison
The practical upshot is this: if your primary care doctor tells you at 70 that you no longer need to see a gynecologist, that may be true for formal cancer screening, but it is not true as a blanket statement about gynecologic care. A vigorous 72-year-old with a family history of breast cancer, ongoing hormone therapy, and urinary leakage she has not mentioned to anyone has multiple reasons to maintain a gynecologic relationship. Meanwhile, a 70-year-old with serious comorbidities and a limited life expectancy might reasonably focus her medical energy elsewhere. Neither answer is wrong, because the question is not really about age.
Barriers That Keep Older Women From Getting Care
Women over 65 are at elevated risk for late-stage diagnoses of gynecologic cancers, pelvic organ disease, incontinence, and infections, partly because they disengage from gynecologic care.17PubMed Central. Factors Affecting Gynecologic and Sexual Assessment in Older Women: A Lesson for Primary Care Providers The reasons are layered. Some women interpret the end of cervical screening as a signal that gynecologic visits are no longer needed at all. Others are uncomfortable with pelvic exams, have mobility challenges that make the exam position difficult, or simply have no symptoms that prompt them to make an appointment. In clinical settings, providers sometimes fail to ask about gynecologic or sexual health in older patients, creating a mutual silence.
Primary care providers are in a position to bridge this gap by incorporating gynecologic health history and symptom questions into annual wellness visits, then referring to a specialist when something warrants further evaluation. A question as simple as “Have you had any vaginal bleeding, discharge, itching, or urinary leakage?” can surface problems that a patient would not have volunteered. The visit does not always have to include a pelvic exam. A symptom-driven conversation can identify who needs further workup and who genuinely does not.
When a Full Pelvic Exam Adds Value and When It Might Not
The role of the routine screening pelvic exam in asymptomatic women has been debated for years. A systematic evidence review for the U.S. Preventive Services Task Force found limited evidence that periodic pelvic exams in asymptomatic women lead to improved health outcomes.18PubMed Central. Periodic Screening Pelvic Examination: Evidence Report and Systematic Review for the US Preventive Services Task Force That finding applies across age groups, not specifically to older women. What it means in practice is that performing a pelvic exam on a 73-year-old who has no symptoms, no vulvar complaints, no bleeding, and no incontinence issues is unlikely to catch a hidden problem. The exam has value when there is a reason for it: symptoms, a known condition that requires monitoring, or a risk factor that warrants surveillance.
This distinction helps resolve the confusion many women feel. You may not need a routine pelvic exam at 70. That is different from saying you do not need a gynecologist. The specialist’s role shifts from screening toward symptom management, chronic condition monitoring, and individualized counseling about hormones, sexual health, and cancer risk. If you have something going on, a gynecologist is the person to see. If you have nothing going on and no risk factors, a periodic check-in with your primary care provider who asks the right questions may be sufficient, with referral to a gynecologist if anything surfaces.
Conditions That Specifically Require Specialist Monitoring
Certain situations make ongoing gynecologic visits non-negotiable regardless of age. If any of the following apply to you, a gynecologist should remain part of your care team:
- Lichen sclerosus or lichen planus: These chronic vulvar conditions require periodic surveillance because of their association with vulvar cancer, and treatment adjustments are common over time.
- History of gynecologic cancer: Survivors of cervical, endometrial, ovarian, or vulvar cancer typically need long-term follow-up that extends well past 70.
- Ongoing hormone therapy: Whether systemic or topical, hormone use warrants periodic review to reassess the risk-benefit balance as your health profile changes.
- Recurrent urinary tract infections: These can be a manifestation of untreated GSM, and a gynecologist can address the underlying cause rather than simply prescribing another course of antibiotics.
- Pelvic organ prolapse: Management options range from pessary fitting to surgery, and the choice depends on your anatomy, symptoms, and overall health.
- Unexplained pelvic or vulvar symptoms: Pain, itching, unusual discharge, or a new lump at any age warrants evaluation.
For women without these conditions, the question of whether to see a gynecologist after 70 is less about medical necessity and more about maintaining access to specialized care. Your needs may be intermittent rather than annual, but knowing you have a gynecologist to call when something comes up is itself a form of preventive care. The worst outcome is the one that research consistently documents: older women presenting with advanced disease because they assumed their gynecologic years were behind them.